PetCaseFinder

Peer-reviewed veterinary case report

How well Simparica chewables kill Asian longhorned ticks on dogs

By Rodriguez, Jessica et al.·Published in Parasites & vectors·2026·Zoetis, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Efficacy of sarolaner in Simparica(sarolaner) chewables and Simparica Trio(sarolaner, moxidectin, and pyrantel chewable tablets) against two US strains of Haemaphysalis longicornis.

Species:
dog

Plain-English summary

A group of dogs was tested to see how well two tick treatments, Simparica and Simparica Trio, worked against the Asian longhorned tick, which is now found in parts of the U.S. Both treatments showed impressive results, reducing tick counts by up to 100% for several weeks after administration. Even at later time points, the treatments still significantly lowered the number of ticks. This means that if your dog is at risk for these ticks, using Simparica or Simparica Trio could be very effective in keeping them tick-free.

People also search for: dog tick prevention · Simparica for ticks · Simparica Trio effectiveness · Asian longhorned tick treatment

Abstract

BACKGROUND: Haemaphysalis longicornis (Asian longhorned tick) is an invasive species now established in the Northeastern and Mid-Atlantic USA. It feeds on mammalian wildlife, livestock, birds, cats, dogs, and humans. Simparicaand Simparica Triocontain sarolaner, a drug in the isoxazoline class, with activity against fleas, ticks, and mites. METHODS: Two laboratory studies were conducted using 30 dogs each, randomized into three groups (n = 10/group): placebo (Pet Tabs), Simparica Trio (minimum dose: 1.2 mg/kg sarolaner, 24 µg/kg moxidectin, 5 mg/kg pyrantel, as pamoate salt), and Simparica (minimum dose: 2.0 mg/kg sarolaner). Treatments were administered once orally on Day 0 according to the approved commercial dosing directions. Each dog was infested with 50 (± 5) unfed viable adult female H. longicornis on Days -2, 7, 14, 21, 30, 37, 49, and 63, and ticks were counted with removal and categorization at 48 h after treatment and each subsequent infestation. Ectoparasitic efficacy was calculated on the basis of the reduction in arithmetic mean of live and dead tick counts in each of the treated groups versus the untreated control group for every time point post infestation. RESULTS: Adequate challenge was demonstrated in both studies on the basis of live tick counts at each time point. For all sarolaner-treated groups, mean live counts were significantly (P ≤ 0.0005) lower than those for the placebo at all time points. For Simparica, in Study 1, the percentage reductions were 100% for all time points up to Day 39. On Days 51 and 65, the percentage reductions were 98.9% and 82.4%, respectively. In Study 2, reductions were 99.7-100% up to Day 65. For Simparica Trio, in Study 1, percentage reductions were 100% up to Day 51. On Day 65, the percentage reduction was 78.4%. In Study 2, reductions were 99.6-100% up to Day 39 and 97.6% and 94.1% on Days 51 and 65, respectively. CONCLUSIONS: Results from these controlled studies demonstrated high efficacy (78.4-100%) of Simparica and Simparica Trio in reducing existing and subsequent infestations of H. longicornis within 48 h for up to 65 days post treatment.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41521310/